Burgess Paul D. — SEC Form 4 filings

SEC reporting owner CIK 1744627. 3 Form 4 filings on record with FilingPulse; latest filed 2026-04-20.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-01-23 to 2026-04-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cerevel Therapeutics Holdings, Inc. (CERE)See Remarks24
Kailera Therapeutics, Inc. (KLRA)See Remarks12

Form 4 filings — Burgess Paul D.

FiledFormIssuerReported transactionsSource
2026-04-204Kailera Therapeutics, Inc. (KLRA)Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2024-08-054Cerevel Therapeutics Holdings, Inc. (CERE)Disposition to issuer (D): 45,727 · Disposition to issuer (D): 95,931 (derivative) · Disposition to issuer (D): 81,065 (derivative) @ $0EDGAR
2024-01-234Cerevel Therapeutics Holdings, Inc. (CERE)Grant/award (A): 81,065 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1744627 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →